Cut Risedronate Drug Holiday to Under 2 Years in Older Patients Cut Risedronate Drug Holiday to Under 2 Years in Older Patients
Risedronate confers less hip fracture protection than alendronate during drug holidays beyond 2 years, so a 2- to 3-year drug holiday for risedronate is likely too long.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 6, 2021 Category: Rheumatology Tags: Diabetes & Endocrinology News Source Type: news
Bone Gains Lost Following Denosumab Stop in Steroid-Treated RA Bone Gains Lost Following Denosumab Stop in Steroid-Treated RA
When denosumab is discontinued, glucocorticoid-treated patients with rheumatoid arthritis need to transition to another osteoporosis therapy.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 28, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news
ACR Updates COVID Vaccine Guidance With Booster Schedule ACR Updates COVID Vaccine Guidance With Booster Schedule
New recommendations advise on the timing of a third vaccine dose for immunocompromised patients, based on current medications and disease activity.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 1, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news
COVID Vax Booster Trial Begun in People With Autoimmune Disease COVID Vax Booster Trial Begun in People With Autoimmune Disease
The trial will investigate the impact of a booster in patients with five autoimmune diseases who are either on or off immunosuppressives.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 30, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news
Bimekizumab Approved in Europe for Psoriasis Treatment Bimekizumab Approved in Europe for Psoriasis Treatment
In the United States, the US Food and Drug Administration is expected to make a decision on approval of bimekizumab for treating psoriasis on October 15.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 25, 2021 Category: Rheumatology Tags: Dermatology News Source Type: news
Tocilizumab Shortage Continues as Pandemic Wears On Tocilizumab Shortage Continues as Pandemic Wears On
Emergency use authorization of tocilizumab for COVID-19 has led to a global shortage, but supplies for rheumatoid arthritis and other inflammatory conditions are faring better — for now.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 19, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news
More Rheumatology Patients Are Using Cannabis: Are You Ready? More Rheumatology Patients Are Using Cannabis: Are You Ready?
Karmela Kim Chan, MD, looks at the many unknowns in play regarding the use of and current state of knowledge about medical marijuana and cannabis-derived drugs in patients with rheumatic diseases.Hospital for Special Surgery (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 17, 2021 Category: Rheumatology Tags: Rheumatology Commentary Source Type: news
Rheumatologists' Industry Payments Rise; Small Minority Gets Most Rheumatologists' Industry Payments Rise; Small Minority Gets Most
A small percentage of US rheumatologists receive the majority of payments from industry.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - July 16, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news
Biologic Treatment Mitigates PsA Risk in Patients With Psoriasis, Study Finds Biologic Treatment Mitigates PsA Risk in Patients With Psoriasis, Study Finds
The findings suggest that continued treatment with biologic DMARDs ' may reduce the risk of incident PsA in patients with moderate to severe chronic plaque psoriasis. 'Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 24, 2021 Category: Rheumatology Tags: Dermatology News Source Type: news
Patients With RA on Rituximab at Risk for Worse COVID Outcomes Patients With RA on Rituximab at Risk for Worse COVID Outcomes
Risk mitigation strategies such as social distancing and wearing masks, especially indoors, remain important for people being treated with rituximab.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 8, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news
EULAR COVID-19 Recommendations Set for Update EULAR COVID-19 Recommendations Set for Update
Conclusions drawn from a systematic literature review largely appear to reinforce the recommendations that have already been made but need further discussion.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 3, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news
Studies Highlight Pandemic's Impact on Patients With RMDs Studies Highlight Pandemic's Impact on Patients With RMDs
From the Europe-based REUMAVID study to the United Kingdom ' s CONTAIN study, some common themes are emerging, with lessons to be learned for future practice.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - May 7, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news
Oarsi 2021 oarsi 2021
Read clinically focused news coverage of key developments from OARSI Connect ‘21Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - May 5, 2021 Category: Rheumatology Tags: Rheumatology Conference Coverage Source Type: news
ANA Testing in a Postpartum Patient at Risk for Dermatomyositis ANA Testing in a Postpartum Patient at Risk for Dermatomyositis
The progression of a 32-year-old woman ' s dermatomyositis -- a rash that resolved during pregnancy, only to recur postpartum, along with fatigue and weakness.HSS Grand Rounds Complex Cases (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - May 4, 2021 Category: Rheumatology Tags: Rheumatology Clinical Case Source Type: news
At-Home, Remotely Supervised Brain Stimulation Offers Pain Relief At-Home, Remotely Supervised Brain Stimulation Offers Pain Relief
At-home, remotely supervised, transcranial direct-current stimulation effectively relieves pain in older patients with osteoarthritis, a small pilot study suggests.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - April 30, 2021 Category: Rheumatology Tags: Neurology & Neurosurgery News Source Type: news
